RBC Capital analyst Brian Abrahams is incrementally positive on Biogen's (NASDAQ: BIIB) appointment of Daniel Karp as Executive Vice President ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE